190
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Patient Characteristics and Predictors of Pulmonary Embolism in Patients Infected with COVID – 19 in Upper Egypt

ORCID Icon, , , &
Pages 201-210 | Received 02 Jan 2023, Accepted 28 Mar 2023, Published online: 06 Apr 2023

References

  • World Health Organization. Coronavirus disease (COVID-2019) situation reports; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed May 1, 2020.
  • World Health Organization. Director-general’s opening remarks at the media briefing on COVID-19, 11 March 2020; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-The-media-briefingon-covid-19---11-march-2020. Accessed April 3, 2023.
  • Li F, Li W, Farzan M, et al. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864–1868. doi:10.1126/science.1116480
  • Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020
  • Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. doi:10.1111/jth.14817
  • Caruso D, Zerunian M, Polici M, et al. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020;3:201237.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Paranjpe I, Fuster V, Lala V, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76:122–124. doi:10.1016/j.jacc.2020.05.001
  • Farmakis IT, Valerio L, Bikdeli B, et al. Annual mortality related to pulmonary embolism in the U.S. before and during the COVID-19 pandemic. J Am Coll Cardiol. 2022;80(16):1579–1581. PMID: 36038034; PMCID: PMC9412135. doi:10.1016/j.jacc.2022.08.721
  • World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance; 2020. Available from: https://www.who.int/docs/defaultsource/coronaviruse/clinical-management-of-novel-cov.pdf. Accessed April 3, 2023.
  • Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791–796.
  • Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4
  • Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi:10.1093/eurheartj/ehz405
  • The Egyptian protocol for management of COVID-19. Available from: https://www.researchgate.net/publication/345813633_Management_Protocol_for_COVID-19_Patients_MoHP_Protocol_for_COVID19_November_2020. Accessed April 3, 2023.
  • Scudiero F, Silverio A, Di Maio M, et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res. 2021;198:34–39. doi:10.1016/j.thromres.2020.11.017
  • Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196. doi:10.1016/j.chest.2020.11.005
  • Hobohm L, Sagoschen I, Barco S, et al. COVID-19 infection and its impact on case fatality in patients with pulmonary embolism. Eur Respir J. 2023;61(1):2200619. PMID: 35981745; PMCID: PMC9411730. doi:10.1183/13993003.00619-2022
  • Miró Ò, Jiménez S, Mebazaa A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021;42(33):3127–3142. PMID: 34164664; PMCID: PMC8344714. doi:10.1093/eurheartj/ehab314
  • Fauvel C, Weizman O, Trimaille A, et al. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J. 2020;41(32):3058–3068. PMID: 32656565; PMCID: PMC7528952. doi:10.1093/eurheartj/ehaa500
  • Hussein A, Mahmoud SED, Awad MS, Mahmoud HEM. Assessment of cardiovascular risk factors in patients with type 2 diabetes in upper Egypt villages. Diabetes Metab Syndr Obes. 2020;13:4737–4746. PMID: 33311991; PMCID: PMC7725276. doi:10.2147/DMSO.S282888
  • Kho J, Ioannou A, Van den Abbeele K, et al. Pulmonary embolism in COVID-19: clinical characteristics and cardiac implications. Am J Emerg Med. 2020;38(10):2142–2146. doi:10.1016/j.ajem.2020.07.054
  • Silva BV, Jorge C, Plácido R, et al. Pulmonary embolism and COVID-19: a comparative analysis of different diagnostic models performance. Am J Emerg Med. 2021;50:526–531. doi:10.1016/j.ajem.2021.09.004
  • Gupta N, Zhao YY, Evans CE. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77–83. doi:10.1016/j.thromres.2019.07.013
  • Garcia-Olivé I, Sintes H, Radua J, et al. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism. Respir Med. 2020;169:106023. doi:10.1016/j.rmed.2020.106023
  • Hajra A, Goel A, Malik AH, et al. Impact of COVID-19 on patients hospitalized with deep vein thrombosis and/or pulmonary embolism: a nationwide analysis. Curr Probl Cardiol. 2023;48(4):101553. PMID: 36528208; PMCID: PMC9749377. doi:10.1016/j.cpcardiol.2022.101553
  • Skulstad H, Cosyns B, Popescu BA, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21(6):592–598.